NORPACT-1 published in @LancetGastroHep. Phase-2 RCT. Neoadjuvant FOLFIRINOX vs upfront surgery in resectable pancreatic head cancer. Great team effort in 12 centers in the Nordic countries
🇳🇴🇸🇪🇩🇰🇫🇮
✅Neoadjuvant FOLFIRINOX did not improve survival compared to upfront surgery
✅Median OS 25.1 vs. 38.5 months (HR 1.52 [1.00-2.33])
✅Resection rates 82% versus 89%
✅Improved histopathology (R0, N0) with neoadjuvant FOLFIRINOX
👉Future trials on treatment sequencing in resectable pancreatic cancer should be biomarker driven
https://t.co/y2pGBrbtm0
If the human being's language is not enough, let's say it with objective and scientific words
S T O P K I L L I N G C I V I L I A N S ST O P
https://t.co/TYkQscnKaL
Commenting on the appointment of two new @ejsotweets Deputy Editors, @raaudisio Editor-in-Chief stated:
1🧵 "Spring cleaning offers the chance to refresh the environment and get set for a new season.
👇
This highly disturbing report finds that sexual harassment, sexual assault, & rape occur frequently & appear to go unchecked in the surgical environment in the UK owing to a combination of a deeply hierarchical structure & a gender & power imbalance.
https://t.co/8edBvlEct2
Pancreatic surgery in 2023, the close relationship between 3 🔑 factors:
🏥 Centralization 🤖 Innovation and 🕸️Dissemination
Example: “MI surgery implementation depends on dissemination and standardization of training”
🎓 competency <> mastery 👑
👉 https://t.co/XZxUeZE84w
🔬 The latest addition to the armamentarium of oncological and surgical approaches is here!
Read the comprehensive digest on Image-guided ablation for liver tumors:
https://t.co/CGylagIKJw
@JJEarnshaw@DocSeeliger#LeadingSurgicalEducation
With broken hearts we announce the passing of our Director, Professor Claudio Bassi. Giant of pancreatic surgery, scientist, husband, father and grandfather, musician. Mentor of generations of surgeons across the world. Your legacy will stay forever ❤️
"Trivial" IPMNs as potential target of surveillance discontinuation are out now on @AGA_Gastro 🔥
🧐 After 5 years of surveillance their risk comparable to that of the general population depending on
📏 Cyst size
👴 Patient Age
But how did we get here?
https://t.co/zUaNcwhssR
An emotional @EurPancClub meeting has come to an end - pandemic and war cannot stop us 💜❤️!
Full of joy after 4️⃣ days of great sessions and amazing old and new friends 🫂
Honoured to be part of @YouppiePancreas, proud of what we have become 🔥🎉��
Can't wait for 2024 🇪🇸!!
After 3 virtual editions due to pandemics and a war, we finally gathered at @EurPancClub 2023 💪
The legacy of @YouppiePancreas reunited to foster new generations of pancreatologists 🐣
With old and new friends.. we already look forward to meeting you in all Santiago 2024 🇪🇸